|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-06 pm EST
|
5-day change | 1st Jan Change | ||
| 2.050 SEK | +2.60% |
|
-1.91% | +4.06% |
| Oct. 27 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| Oct. 27 | Irlab receives positive patent notice in the US for IRL1117 | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IRLAB THERAPEUTICS AB | Other Pharmaceuticals | +2.60% | -1.91% | +4.06% | -14.58% | -95.36% | 30.86M |  | |  |
- Stock Market
- Stocks
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
